|
2018
|
Invention
|
Inhibitors of rorϒ. The present disclosure relates to processes for the production of salts and c... |
|
|
Invention
|
Inhibitors of ror gamma. The present disclosure relates to salts and crystalline forms of a compo... |
|
|
Invention
|
Inhibitors of beta-secretase.
The present invention relates to spirocyclic acylguanidines and th... |
|
2017
|
Invention
|
Inhibitors of the menin-mll interaction. The present invention is directed to inhibitors of the i... |
|
|
Invention
|
Inhibitors of ror gamma. The salts and crystalline forms of a compound having the formula (1) and... |
|
|
Invention
|
Liver x receptor modulators.
Provided herein are novel compounds and pharmaceutically acceptable... |
|
|
Invention
|
Benzimidazole derivatives as modulators of ror-gamma. Provided are novel compounds of Formula I: ... |
|
2016
|
Invention
|
Inhibitors of the menin-mll interaction.
The present invention is directed to inhibitors of the ... |
|
|
Invention
|
Inhibitors of beta-secretase. The present invention relates to spirocyclic acylguanidines and the... |
|
|
Invention
|
Modulators of ror-gamma. Provided are novel compounds of Formula I: pharmaceutically acceptable s... |
|
|
Invention
|
Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline. ... |
|
2015
|
Invention
|
Compounds for use in treating rett syndrome.
Provided herein are compounds and pharmaceutically ... |
|
|
Invention
|
Dihydropyrrolopyridine inhibitors of ror-gamma. Provided are novel compounds of Formula (I): phar... |
|
|
Invention
|
Piperazine derivatives as liver x receptor modulators. Provided are novel compounds of Formula (I... |
|
|
Invention
|
Compounds for use in treating acute coronary syndrome and related conditions.
Provided herein ar... |
|
|
Invention
|
Compounds for use in treating acute coronary syndrome and related conditions. Provided herein are... |
|
|
Invention
|
Purine derivatives as cd73 inhibitors for the treatment of cancer. Provided are novel compounds, ... |
|
|
Invention
|
Compounds for use in treating skin cancers.
Provided herein are compounds and pharmaceutically a... |
|
2014
|
Invention
|
Inhibitors of beta-secretase. The present invention relates to compounds represented by Structura... |
|
|
Invention
|
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their u... |
|
|
Invention
|
Thiazolopyrrolidine inhibitors of ror-gamma. Provided are novel compounds of Formula (I): pharmac... |
|
2013
|
Invention
|
Inhibitors of beta-secretase. The present invention is directed to a compound represented by the ... |
|
|
Invention
|
Inhibitors of β-secretase. The present invention relates to spirocyclic indane imidazole 4-amines... |
|
|
Invention
|
Inhibitors of beta-secretase. The present invention relates to spirocyclic indane imidazole 4-ami... |
|
|
Invention
|
Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline. T... |
|
|
Invention
|
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1. Disclosed are compounds represented... |
|
|
Invention
|
Liver x receptor modulators. Provided herein are novel compounds and pharmaceutically acceptable ... |
|
|
Invention
|
Inhibitors of β-secretase. The present invention relates to spirocyclic acylguanidines and their ... |
|
|
Invention
|
Carbamate and urea inhibitors of 11-beta-hydroxysteroid dehydrogenase 1. This invention relates t... |
|
|
Invention
|
Salts of methyl 2-((r)-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3-((r)-tetrahydro-2h-pyran-3-y... |
|
2012
|
Invention
|
Piperidine renin inhibitors. The present invention is directed to aspartic protease inhibitors re... |
|
2010
|
Invention
|
Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1. Disclosed are compounds represented ... |
|
|
Invention
|
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure... |
|
2009
|
Invention
|
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1. 1-5) pharmaceutically acceptable salts there... |
|
2004
|
P/S
|
Prescription pharmaceutical drug development services |
